What is the address of Société Médicale BALOMENOU MARINAKIS?

The registered office of Société Médicale BALOMENOU MARINAKIS is located at Rue Chevelot 5, 6110 Montigny-le-Tilleul.

Is Société Médicale BALOMENOU MARINAKIS still active?

Yes. According to the CBE (17 September 2026) Société Médicale BALOMENOU MARINAKIS is active, legal situation “Normale toestand”, started on 19 December 2014.

Is Société Médicale BALOMENOU MARINAKIS registered on Peppol?

No, Société Médicale BALOMENOU MARINAKIS is currently not registered on the Peppol network.

What is the enterprise number of Société Médicale BALOMENOU MARINAKIS?

The enterprise number of Société Médicale BALOMENOU MARINAKIS is BE0507612183.

When was Société Médicale BALOMENOU MARINAKIS founded?

Société Médicale BALOMENOU MARINAKIS was founded on 19 December 2014.

Who are the directors of Société Médicale BALOMENOU MARINAKIS?

According to the 2025 annual accounts, the directors of Société Médicale BALOMENOU MARINAKIS are: SPYRIDOULA BALOMENOU, SOTIRIOS MARINAKIS.

Is Société Médicale BALOMENOU MARINAKIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 December 2014; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Société Médicale BALOMENOU MARINAKIS make in 2025?

Société Médicale BALOMENOU MARINAKIS posted a profit after taxes of € 78,934 in financial year 2025.

What is the revenue of Société Médicale BALOMENOU MARINAKIS?

As a small company, Société Médicale BALOMENOU MARINAKIS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 280,243.

Société Médicale BALOMENOU MARINAKIS (Private Limited)

Dossier Société Médicale BALOMENOU MARINAKIS, printed on 17 September 2026 from databakkes.be/en/0507612183/societe-medicale-balomenou-marinakis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Société Médicale BALOMENOU MARINAKIS from Montigny-le-Tilleul, company number BE0507612183, closed financial year 2025 with a result of € 78,934 after tax. For that financial year Société Médicale BALOMENOU MARINAKIS recorded a gross margin of € 280,243 and equity of € 296,850. Compared with financial year 2024, the result moved from € 103,774 to € 78,934. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 296,850

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 78,934

▼ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 220,243

▲ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 76,600 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 41,545

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,161

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,979

▲ 179% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 220,336 Gross margin 2022: € 220,336 First fiscal year in the series	€ 179,831 Gross margin 2023: € 179,831 ▼ 18% vs 2022 (€ 220,336) Unfavourable step	€ 276,579 Gross margin 2024: € 276,579 ▲ 54% vs 2023 (€ 179,831) Favourable step	€ 280,243 Gross margin 2025: € 280,243 ▲ 1% vs 2024 (€ 276,579) Favourable step	▲ 1%
Profit after taxes	€ 66,420 Profit after taxes 2022: € 66,420 First fiscal year in the series	€ 101,469 Profit after taxes 2023: € 101,469 ▲ 53% vs 2022 (€ 66,420) Favourable step	€ 103,774 Profit after taxes 2024: € 103,774 ▲ 2% vs 2023 (€ 101,469) Favourable step	€ 78,934 Profit after taxes 2025: € 78,934 ▼ 24% vs 2024 (€ 103,774) Unfavourable step	▼ 24%
Equity	€ 197,024 Equity 2022: € 197,024 First fiscal year in the series	€ 226,493 Equity 2023: € 226,493 ▲ 15% vs 2022 (€ 197,024) Favourable step	€ 294,516 Equity 2024: € 294,516 ▲ 30% vs 2023 (€ 226,493) Favourable step	€ 296,850 Equity 2025: € 296,850 ▲ 1% vs 2024 (€ 294,516) Favourable step	▲ 1%
Total debts	€ 35,785 Total debts 2022: € 35,785 First fiscal year in the series	€ 93,827 Total debts 2023: € 93,827 ▲ 162% vs 2022 (€ 35,785) Unfavourable step	€ 40,051 Total debts 2024: € 40,051 ▼ 57% vs 2023 (€ 93,827) Favourable step	€ 79,761 Total debts 2025: € 79,761 ▲ 99% vs 2024 (€ 40,051) Unfavourable step	▲ 99%
Cash	€ 108,000 Cash 2022: € 108,000 First fiscal year in the series	€ 133,043 Cash 2023: € 133,043 ▲ 23% vs 2022 (€ 108,000) Favourable step	€ 164,301 Cash 2024: € 164,301 ▲ 23% vs 2023 (€ 133,043) Favourable step	€ 220,243 Cash 2025: € 220,243 ▲ 34% vs 2024 (€ 164,301) Favourable step	▲ 34%
Retained profit	€ 190,224 Retained profit 2022: € 190,224 First fiscal year in the series	€ 217,833 Retained profit 2023: € 217,833 ▲ 15% vs 2022 (€ 190,224) Favourable step	€ 285,856 Retained profit 2024: € 285,856 ▲ 31% vs 2023 (€ 217,833) Favourable step	€ 288,190 Retained profit 2025: € 288,190 ▲ 1% vs 2024 (€ 285,856) Favourable step	▲ 1%
Dividend	€ 13,500 Dividend 2022: € 13,500 First fiscal year in the series	€ 72,000 Dividend 2023: € 72,000 ▲ € 58,500 vs 2022 (€ 13,500) Unchanged	€ 35,750 Dividend 2024: € 35,750 ▼ 50% vs 2023 (€ 72,000) Unchanged	€ 76,600 Dividend 2025: € 76,600 ▲ 114% vs 2024 (€ 35,750) Unchanged	▲ 114%
Balance sheet total	€ 232,809 Balance sheet total 2022: € 232,809 First fiscal year in the series	€ 320,320 Balance sheet total 2023: € 320,320 ▲ 38% vs 2022 (€ 232,809) Unchanged	€ 334,568 Balance sheet total 2024: € 334,568 ▲ 4% vs 2023 (€ 320,320) Unchanged	€ 376,612 Balance sheet total 2025: € 376,612 ▲ 13% vs 2024 (€ 334,568) Unchanged	▲ 13%

Key figures of Société Médicale BALOMENOU MARINAKIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Société Médicale BALOMENOU MARINAKIS?

What happened at Société Médicale BALOMENOU MARINAKIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 78,934 (▼ 24% vs 2024). filed late Source: NBB ↗
May 7, 2015 New establishment in Charleroi. KBO
2014 SPYRIDOULA BALOMENOU became a director. NBB
2014 SOTIRIOS MARINAKIS became a director. NBB
Dec 19, 2014 Start of the company according to the CBE. KBO

In short

From € 66,420 profit in 2022 to € 78,934 profit in 2025.

Paid € 141,883 in corporate taxes since 2022.

Best year ever: 2024, with € 103,774 profit.

Paid out € 197,850 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Société Médicale BALOMENOU MARINAKIS? We notify you, reason included.

Follow Société Médicale BALOMENOU MARINAKIS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SPYRIDOULA BALOMENOU SOTIRIOS MARINAKIS

Société Médicale BALOMENOU MARINAKIS

Behind Société Médicale BALOMENOU MARINAKIS are SPYRIDOULA BALOMENOU and SOTIRIOS MARINAKIS.

See the full network in the app

Directors

According to the 2025 annual accounts

SPYRIDOULA BALOMENOU

Manager

since 2014

SOTIRIOS MARINAKIS

Manager

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Chevelot 5

6110 Montigny-le-Tilleul

2.241.768.978

Chaussée de Bruxelles 140

6042 Charleroi

Active since 7 May 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0507.612.183
VAT number: BE 0507.612.183
Registered office: Rue Chevelot 5, 6110 Montigny-le-Tilleul
Names & denominations: Société Médicale BALOMENOU MARINAKIS · SBM Médicale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 December 2014
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗